CK Life Sciences Int'l., (Holdings) Inc. reported consolidated cash flow results for the year ended December 31, 2013. For the year, the company reported net cash from operating activities of HKD 267,056,000 against HKD 435,403,000 a year ago. Purchases of property, plant and equipment was HKD 139,594,000 against HKD 89,181,000 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.365 HKD | +5.80% | +7.35% | -41.13% |
04-05 | CK Life Sciences to Present Pre-Clinical Data for Two Cancer Vaccines; Shares Up 11% | MT |
03-19 | CK Life Sciences Int'l., Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-41.13% | 424M | |
+11.32% | 7.78B | |
+1.64% | 7.38B | |
+10.50% | 6.52B | |
-6.69% | 3.67B | |
-13.51% | 3.44B | |
-10.10% | 1.17B | |
+8.34% | 934M | |
-41.81% | 879M | |
-19.81% | 836M |
- Stock Market
- Equities
- 775 Stock
- News CK Life Sciences Int'l., (Holdings) Inc.
- CK Life Sciences Int'l., Inc. Reports Consolidated Cash Flow Results for the Year Ended December 31, 2013